The Grant for Oncology Innovation (GOI) is an initiative funded by EMD Serono, a business of Merck KGaA, Darmstadt, Germany, to identify and support innovative projects to advance research on personalized treatment for solid tumors.
The grant program was first launched to coincide with the European Cancer Congress (ECCO-ESMO-ESTRO) in Amsterdam, 27 Sept - 1 Oct 2013.
The three winners of the first GOI award were announced during an Award Ceremony that took place in Madrid, Spain on Friday September 26, 2014.
The three winners of the second GOI award were announced during an Award Ceremony that took place in Vienna on Friday September 25, 2015.
Applications for the 2016 grant are now open. Should you wish to apply, please send an email to email@example.com to request an application form.
The deadline for submitting your application is Friday January 22, 2016